Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer
Crossref DOI link: https://doi.org/10.1186/s12967-017-1265-x
Published Online: 2017-08-01
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kwak, Yoonjin
Yun, Sumi
Nam, Soo Kyung
Seo, An Na
Lee, Kyu Sang
Shin, Eun
Oh, Heung-Kwon
Kim, Duck Woo
Kang, Sung Bum
Kim, Woo Ho
Lee, Hye Seung
Funding for this research was provided by:
Korea Health Industry Development Institute (HI14C1813)